NADH-ubiquinone oxidoreductase 29 kDa subunit Antibody

Target Protein: NADH-Ubiquinone Oxidoreductase 29 kDa Subunit

The 29 kDa subunit is an accessory component of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), which facilitates electron transfer from NADH to ubiquinone during oxidative phosphorylation . Unlike core catalytic subunits, the 29 kDa subunit is not directly involved in electron transfer but stabilizes the enzyme’s structure .

Key Features of the 29 kDa Subunit:

• Molecular Weight: ~29 kDa (varies slightly across species) .

• Localization: Embedded in the mitochondrial inner membrane .

• Function: Contributes to Complex I assembly and stability; mutations may disrupt respiratory chain activity .

Role in Mitochondrial Disorders

Mutations or deficiencies in nuclear-encoded Complex I subunits, including the 29 kDa subunit, disrupt electron transport, leading to pathologies such as Leigh syndrome and cardiomyopathy . For example, cells lacking mitochondrial-encoded subunits (e.g., ND4/ND5) show impaired Complex I assembly, highlighting interdependencies between nuclear and mitochondrial subunits .

Antibody Validation

• Specificity: Validated via knockout cell lines and immunoprecipitation .

• Cross-Reactivity: Shows reactivity across humans, mice, and rats, with minor variations in epitope conservation .

Challenges and Future Directions

• Diagnostic Limitations: While antibodies aid in research, clinical diagnostics require pairing with genetic testing due to overlapping phenotypes in mitochondrial diseases .

• Therapeutic Potential: Targeting Complex I subunits with antibodies could enable biomarker discovery for neurodegenerative diseases .